BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27233293)

  • 1. Biliary Elimination of Pemetrexed Is Dependent on Mrp2 in Rats: Potential Mechanism of Variable Response in Nonalcoholic Steatohepatitis.
    Dzierlenga AL; Clarke JD; Klein DM; Anumol T; Snyder SA; Li H; Cherrington NJ
    J Pharmacol Exp Ther; 2016 Aug; 358(2):246-53. PubMed ID: 27233293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Steatohepatitis Modulates Membrane Protein Retrieval and Insertion Processes.
    Dzierlenga AL; Clarke JD; Cherrington NJ
    Drug Metab Dispos; 2016 Nov; 44(11):1799-1807. PubMed ID: 27604106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-by-Environment Interaction of Bcrp
    Toth EL; Li H; Dzierlenga AL; Clarke JD; Vildhede A; Goedken M; Cherrington NJ
    Drug Metab Dispos; 2018 Nov; 46(11):1478-1486. PubMed ID: 30166404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.
    Dzierlenga AL; Clarke JD; Hargraves TL; Ainslie GR; Vanderah TW; Paine MF; Cherrington NJ
    J Pharmacol Exp Ther; 2015 Mar; 352(3):462-70. PubMed ID: 25512370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.
    Canet MJ; Hardwick RN; Lake AD; Dzierlenga AL; Clarke JD; Goedken MJ; Cherrington NJ
    Drug Metab Dispos; 2015 Feb; 43(2):266-72. PubMed ID: 25488932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease.
    Lickteig AJ; Fisher CD; Augustine LM; Aleksunes LM; Besselsen DG; Slitt AL; Manautou JE; Cherrington NJ
    Drug Metab Dispos; 2007 Oct; 35(10):1970-8. PubMed ID: 17640958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
    Canet MJ; Merrell MD; Hardwick RN; Bataille AM; Campion SN; Ferreira DW; Xanthakos SA; Manautou JE; A-Kader HH; Erickson RP; Cherrington NJ
    Drug Metab Dispos; 2015 Jun; 43(6):829-35. PubMed ID: 25788542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis.
    Dzierlenga AL; Cherrington NJ
    J Biochem Mol Toxicol; 2018 Mar; 32(3):e22035. PubMed ID: 29341352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
    Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
    J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD
    Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis.
    Hardwick RN; Fisher CD; Street SM; Canet MJ; Cherrington NJ
    Drug Metab Dispos; 2012 Mar; 40(3):450-60. PubMed ID: 22112382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
    Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian Clock Is Involved in Regulation of Hepatobiliary Transport Mediated by Multidrug Resistance-Associated Protein 2.
    Oh JH; Lee JH; Han DH; Cho S; Lee YJ
    J Pharm Sci; 2017 Sep; 106(9):2491-2498. PubMed ID: 28479363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
    Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
    Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
    Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained intrahepatic glutathione depletion causes proteasomal degradation of multidrug resistance-associated protein 2 in rat liver.
    Sekine S; Mitsuki K; Ito K; Kugioka S; Horie T
    Biochim Biophys Acta; 2012 Jun; 1822(6):980-7. PubMed ID: 22330094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III.
    Chatterjee S; Mukherjee S; Sankara Sivaprasad LVJ; Naik T; Gautam SS; Murali BV; Hadambar AA; Gunti GR; Kuchibhotla V; Deyati A; Basavanthappa S; Ramarao M; Mariappan TT; Zinker BA; Zhang Y; Sinz M; Shen H
    J Pharmacol Exp Ther; 2021 Jan; 376(1):29-39. PubMed ID: 33127749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice.
    Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL
    Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.